Douglas Golenbock to Vaccinia virus
This is a "connection" page, showing publications Douglas Golenbock has written about Vaccinia virus.
Connection Strength
0.087
-
Lysakova-Devine T, Keogh B, Harrington B, Nagpal K, Halle A, Golenbock DT, Monie T, Bowie AG. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J Immunol. 2010 Oct 01; 185(7):4261-71.
Score: 0.087